Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,900.00p
   
  • Change Today:
    -70.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 7,259
  • Market Cap: £151.52m
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 13.50 10.10 151.50p 19.6 n/a -2% 155.00p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2025 14 n/a 14 14 14 15
 
Earnings
30-Jun-2025 151.50p n/a 151.50p 171.00p 171.00p 179.30p
 
Dividend
30-Jun-2025 155.00p n/a 155.00p 160.00p 160.00p 172.00p
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 0 0 0
 
Average Rec n/a n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 2,900.00p
Change Today -70.00p
% Change -2.36 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 7,259
Shares Issued 5.22m
Market Cap £151.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average27.48% below the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Price Trend
59.75% below the market average59.75% below the market average59.75% below the market average59.75% below the market average59.75% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Income
37.24% above the market average37.24% above the market average37.24% above the market average37.24% above the market average37.24% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 28-May-2025

Time Volume / Share Price
15:33 16 @ 2,917.00p
15:24 34 @ 2,917.00p
15:17 40 @ 2,867.00p
15:00 119 @ 2,885.00p
14:54 249 @ 2,885.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page